Paper Details

  1. Home
  2. Paper Details

A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder.

Author: SanbergPaul R, ShytleR Douglas, SilverArchie A, WilkinsonBerney J

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Transdermal nicotine may be a potentially useful strategy for the treatment of ADHD, but therapeutic uses of nicotine are limited due to side effects.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To test the hypothesis that transdermal nicotine would be efficacious for the treatment of children and adolescents with attention deficit hyperactivity disorder (ADHD). METHOD: This was a double-blind, placebo-controlled, randomized, pilot trial that compared the effects of daily transd...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/15622970209150616

データ提供：米国国立医学図書館（NLM）

Nicotine for ADHD: A Desert Oasis or a Mirage?

This research explores the potential of transdermal nicotine as a treatment for attention deficit hyperactivity disorder (ADHD), a condition that affects many children and adolescents. It's like venturing into the desert with a new map, seeking a new path to alleviate this common ailment.

Nicotine's Promise: A New Oasis?

The study showed that transdermal nicotine significantly reduced ADHD symptoms in children and adolescents. This finding suggests that nicotine, often associated with its addictive properties, could potentially offer a new avenue for treating this disorder. It's like finding a hidden oasis, promising a potential source of relief.

Navigating the Side Effects: A Desert Mirage?

While the study shows promise, it also highlights the potential for side effects associated with nicotine, like a desert mirage that can create false hope. These side effects can be a significant barrier to the use of nicotine as a treatment option for ADHD.

Dr. Camel's Conclusion

This study delves into the complex world of nicotine and its potential therapeutic role in ADHD. It's like uncovering a hidden oasis in the desert, offering a glimmer of hope for new treatment options. However, like a mirage, we must navigate the potential side effects carefully. Further research is needed to explore ways to optimize the therapeutic benefits of nicotine while minimizing its potential risks.

Date :
  1. Date Completed 2003-01-23
  2. Date Revised 2019-11-06
Further Info :

Pubmed ID

12478880

DOI: Digital Object Identifier

10.3109/15622970209150616

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.